Cite
HARVARD Citation
Lawton, J. et al. (2019). Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience. United European Gastroenterology journal. 7 (7), pp. 908-913. [Online].